Markets

Agios Pharmaceuticals prices IPO at $18, above the range

Agios Pharmaceuticals, a biotech developing metabolic treatments for cancer and rare genetic diseases, raised $106 million by offering 5.9 million shares at $18, above the range of $14 to $16. Agios had originally planned to sell 5.0 million shares. Agios Pharmaceuticals plans to list on the NASDAQ under the symbol AGIO. J.P. Morgan and Goldman Sachs acted as joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AGIO

Other Topics

IPOs

Latest Markets Videos